ClinicalTrials.Veeva

Menu

Hidradenitis Suppurativa Prospective Observational Registry and Biospecimen Repository (HS PROGRESS)

University of California San Francisco (UCSF) logo

University of California San Francisco (UCSF)

Status

Enrolling

Conditions

Hidradenitis Suppurativa

Study type

Observational

Funder types

Other

Identifiers

NCT04115566
18-27002

Details and patient eligibility

About

Hidradenitis suppurativa (HS) is a common and debilitating skin disease that is poorly understood and understudied. As a result, little is known about disease prognosis and few effective treatments exist for this condition. This prospective observational cohort study aims to comprehensively characterize the clinical and biological features of HS. The results of this research will provide a basis for the development of an HS clinical classification system and identification of potential treatments for HS.

Enrollment

3,000 estimated patients

Sex

All

Ages

10+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Male or female ≥ 10 years of age
  2. Diagnosis of HS by a dermatologist or practitioner experienced in making a diagnosis of HS
  3. Written informed consent (and assent when applicable) obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study.

Exclusion criteria

  1. Inability to give informed consent or unavailability of a parent/guardian who is able and willing to give informed consent.

Trial contacts and locations

1

Loading...

Central trial contact

Ashley Yates, MMS, PA-C

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems